253 related articles for article (PubMed ID: 32057762)
21. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.
Hormigo A; Abrey L; Heinemann MH; DeAngelis LM
Br J Haematol; 2004 Jul; 126(2):202-8. PubMed ID: 15238140
[TBL] [Abstract][Full Text] [Related]
22. Primary vitreoretinal lymphoma.
Mulay K; Narula R; Honavar SG
Indian J Ophthalmol; 2015 Mar; 63(3):180-6. PubMed ID: 25971162
[TBL] [Abstract][Full Text] [Related]
23. B-scan ultrasound and cytology of the vitreous in primary central nervous system lymphoma with vitreoretinal involvement.
Lai J; Chen K; Shi HM; Zhuang L; Zhou X; Xiao JJ; Li Y; Chen BB; Wang QP
Int J Ophthalmol; 2019; 12(6):1001-1007. PubMed ID: 31236360
[TBL] [Abstract][Full Text] [Related]
24. The molecular hallmarks of primary and secondary vitreoretinal lymphoma.
Bonzheim I; Sander P; Salmerón-Villalobos J; Süsskind D; Szurman P; Gekeler F; Spitzer MS; Steinhilber J; Kohler E; Büssgen M; Schittenhelm J; Salaverria I; Campo E; Coupland SE; Quintanilla-Martinez L; Fend F
Blood Adv; 2022 Mar; 6(5):1598-1607. PubMed ID: 34448823
[TBL] [Abstract][Full Text] [Related]
25. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
[TBL] [Abstract][Full Text] [Related]
26. Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma.
Chan CC; Sen HN
Discov Med; 2013 Feb; 15(81):93-100. PubMed ID: 23449111
[TBL] [Abstract][Full Text] [Related]
27. Primary vitreoretinal lymphoma: a diagnostic and management challenge.
Soussain C; Malaise D; Cassoux N
Blood; 2021 Oct; 138(17):1519-1534. PubMed ID: 34036310
[TBL] [Abstract][Full Text] [Related]
28. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
[TBL] [Abstract][Full Text] [Related]
29. Optic Nerve Infiltration in Primary Central Nervous System Lymphoma.
Ahle G; Touitou V; Cassoux N; Bouyon M; Humbrecht C; Oesterlé H; Baraniskin A; Soussain C; Nguyen-Them L; Gaultier C; Hoang-Xuan K; Houillier C
JAMA Neurol; 2017 Nov; 74(11):1368-1373. PubMed ID: 28973119
[TBL] [Abstract][Full Text] [Related]
30. Evaluating optical coherence tomography (OCT) findings as potential biomarkers in central nervous system (CNS) lymphoma with or without ocular involvement.
Hassan M; Halim MS; Afridi R; Nguyen NV; Nguyen QD; Sepah YJ
Int J Retina Vitreous; 2021 Nov; 7(1):70. PubMed ID: 34819169
[TBL] [Abstract][Full Text] [Related]
31. Ocular manifestation of primary nervous system lymphoma: what can be expected from imaging?
Küker W; Herrlinger U; Grönewäller E; Rohrbach JM; Weller M
J Neurol; 2002 Dec; 249(12):1713-6. PubMed ID: 12529795
[TBL] [Abstract][Full Text] [Related]
32. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma.
Whitcup SM; Stark-Vancs V; Wittes RE; Solomon D; Podgor MJ; Nussenblatt RB; Chan CC
Arch Ophthalmol; 1997 Sep; 115(9):1157-60. PubMed ID: 9298057
[TBL] [Abstract][Full Text] [Related]
33. Primary intraocular lymphoma: A review.
Choi JY; Kafkala C; Foster CS
Semin Ophthalmol; 2006; 21(3):125-33. PubMed ID: 16912010
[TBL] [Abstract][Full Text] [Related]
34. The clinical spectrum of ocular lymphoma.
Peterson K; Gordon KB; Heinemann MH; DeAngelis LM
Cancer; 1993 Aug; 72(3):843-9. PubMed ID: 8334638
[TBL] [Abstract][Full Text] [Related]
35. Primary Central Nervous System Lymphoma (PCNSL) - A Rare and Unusual Presentation of Rapidly Progressive Major Cognitive Dysfunction.
Nand L; Gupta D; Sharma S; Kumar S
J Assoc Physicians India; 2021 Feb; 69(2):68-70. PubMed ID: 33527818
[TBL] [Abstract][Full Text] [Related]
36. Cytological diagnosis of vitreoretinal lymphomas: A case series.
Quintyn JC; Olle P; Courtade-Saidi M; Laurent C; Obéric L; Quintyn-Ranty ML
Cytopathology; 2019 Jul; 30(4):385-392. PubMed ID: 31033057
[TBL] [Abstract][Full Text] [Related]
37. Ocular involvement in primary central nervous system lymphoma: an increasing clinical problem?
Roos DE; O'Brien PC; Crompton JL
Australas Radiol; 1993 Nov; 37(4):372-4. PubMed ID: 8257339
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for intraocular involvement in patients with primary central nervous system lymphoma.
Cho BJ; Yu HG
J Neurooncol; 2014 Dec; 120(3):523-9. PubMed ID: 25119002
[TBL] [Abstract][Full Text] [Related]
39. [Special hematological diagnostics and therapy options for ocular lymphoma taking CNS involvement into account].
Korfel A; Schlegel U; Schroers R
Ophthalmologe; 2015 Mar; 112(3):231-6. PubMed ID: 25721677
[TBL] [Abstract][Full Text] [Related]
40. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes.
Levasseur SD; Wittenberg LA; White VA
JAMA Ophthalmol; 2013 Jan; 131(1):50-5. PubMed ID: 23307208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
